A randomized clinical trial comparing cervical dysplasia treatment with cryotherapy vs loop electrosurgical excision procedure in HIV‐seropositive women from Johannesburg, South Africa

[1]  T. Wu,et al.  Current state in the development of candidate therapeutic HPV vaccines , 2016, Expert review of vaccines.

[2]  E. Takashima,et al.  Vaccine candidates for malaria: what’s new? , 2016, Expert review of vaccines.

[3]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[4]  Jennifer S. Smith,et al.  Topical 5-fluorouracil for treatment of cervical intraepithelial neoplasia 2: a randomized controlled trial. , 2014, American journal of obstetrics and gynecology.

[5]  Richard D Moore,et al.  Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study , 2013, Journal of acquired immune deficiency syndromes.

[6]  M. Hudgens,et al.  Validation of Cervical Cancer Screening Methods in HIV Positive Women from Johannesburg South Africa , 2013, PloS one.

[7]  P. Memiah,et al.  Prevalence and Risk Factors Associated with Precancerous Cervical Cancer Lesions among HIV-Infected Women in Resource-Limited Settings , 2012, AIDS research and treatment.

[8]  S. Feldman,et al.  Management of cervical precancers: a global perspective. , 2012, Hematology/oncology clinics of North America.

[9]  A. Stang Randomized controlled trials-an indispensible part of clinical research. , 2011, Deutsches Arzteblatt international.

[10]  J. Stringer,et al.  Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review , 2010, BMC women's health.

[11]  P. Michelow,et al.  Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa , 2009, Cancer Causes & Control.

[12]  J. Stringer,et al.  Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia. , 2009, AIDS.

[13]  J. Palefsky Human papillomavirus-related disease in people with HIV , 2009, Current opinion in HIV and AIDS.

[14]  B. Thiers Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2009 .

[15]  Jennifer S. Smith,et al.  HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy , 2008, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[16]  J. Stringer,et al.  Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field. , 2008, Gynecologic oncology.

[17]  J. McIntyre,et al.  Predictors of persistent cytologic abnormalities after treatment of cervical intraepithelial neoplasia in Soweto, South Africa: a cohort study in a HIV high prevalence population , 2008, BMC Cancer.

[18]  Ross J. Harris,et al.  Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies , 2008, The Lancet.

[19]  Instituto Fernandes Figueira Recurrence of cervical intraepithelial neoplasia grades 2 or 3 in HIV-infected women treated by large loop excision of the transformation zone ( LLETZ ) , 2008 .

[20]  M. Jacoba,et al.  Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings , 2005 .

[21]  A. Mocroft,et al.  Decline in the AIDS and death rates in the EuroSIDA study: an observational study , 2003, The Lancet.

[22]  Diane Solomon,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2003, Journal of lower genital tract disease.

[23]  Z. Chirenje,et al.  A randomised clinical trial of loop electrosurgical excision procedure (LEEP) versus cryotherapy in the treatment of cervical intraepithelial neoplasia. , 2001, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[24]  M. Kazatchkine,et al.  Increased Risk of Cervical Disease Among Human Immunodeficiency Virus–Infected Women With Severe Immunosuppression and High Human Papillomavirus Load , 2000, Obstetrics and gynecology.

[25]  Soler,et al.  Cervical cancer screening in developing countries. , 2000, Primary care update for Ob/Gyns.

[26]  R. Greenblatt,et al.  Prevalence and predictors of squamous cell abnormalities in papanicolaou smears from women infected with HIV-1 , 1999 .